Delen, L. A. Et Al. 2022. EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA. ACTA CLINICA CROATICA , vol.61, no.3 , 403-411.

Delen, L. A., Gök, A., Kasapoğlu, U. S., Cagasar, O., Gok, Z., Berber, N., ... Derya, S.(2022). EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA. ACTA CLINICA CROATICA , vol.61, no.3, 403-411.

Delen, Leman Et Al. "EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA," ACTA CLINICA CROATICA , vol.61, no.3, 403-411, 2022

Delen, Leman A. Et Al. "EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA." ACTA CLINICA CROATICA , vol.61, no.3, pp.403-411, 2022

Delen, L. A. Et Al. (2022) . "EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA." ACTA CLINICA CROATICA , vol.61, no.3, pp.403-411.

@article{article, author={Leman Acun Delen Et Al. }, title={EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA}, journal={ACTA CLINICA CROATICA}, year=2022, pages={403-411} }